Found: 11
Select item for more details and to access through your institution.
The interplay mechanism between IDH mutation, MGMT-promoter methylation, and PRMT5 activity in the progression of grade 4 astrocytoma: unraveling the complex triad theory.
- Published in:
- Oncology Research, 2024, v. 32, n. 6, p. 1037, doi. 10.32604/or.2024.051112
- By:
- Publication type:
- Article
MicroRNAs in thyroid cancer with focus on medullary thyroid carcinoma: potential therapeutic targets and diagnostic/prognostic markers and web based tools.
- Published in:
- Oncology Research, 2024, v. 32, n. 6, p. 1011, doi. 10.32604/or.2024.049235
- By:
- Publication type:
- Article
Bendamustine and rituximab as frontline therapy in extranodal marginal zone lymphoma: a single-institution experience.
- Published in:
- Oncology Research, 2024, v. 32, n. 6, p. 1031, doi. 10.32604/or.2024.046885
- By:
- Publication type:
- Article
PHLDA2 reshapes the immune microenvironment and induces drug resistance in hepatocellular carcinoma.
- Published in:
- Oncology Research, 2024, v. 32, n. 6, p. 1063, doi. 10.32604/or.2024.047078
- By:
- Publication type:
- Article
Preclinical evaluation of cyclophosphamide and fludarabine combined with CD19 CAR-T in the treatment of B-cell hematologic malignancies in vivo.
- Published in:
- Oncology Research, 2024, v. 32, n. 6, p. 1109, doi. 10.32604/or.2024.049792
- By:
- Publication type:
- Article
5-Fluorouracil dose escalation generated desensitized colorectal cancer cells with reduced expression of protein methyltransferases and no epithelial-to-mesenchymal transition potential.
- Published in:
- Oncology Research, 2024, v. 32, n. 6, p. 1047, doi. 10.32604/or.2024.049173
- By:
- Publication type:
- Article
New insights into ATR inhibition in muscle invasive bladder cancer: The role of apolipoprotein B mRNA editing catalytic subunit 3B.
- Published in:
- Oncology Research, 2024, v. 32, n. 6, p. 1021, doi. 10.32604/or.2024.048919
- By:
- Publication type:
- Article
CircMYBL2 facilitates hepatocellular carcinoma progression by regulating E2F1 expression.
- Published in:
- Oncology Research, 2024, v. 32, n. 6, p. 1129, doi. 10.32604/or.2024.047524
- By:
- Publication type:
- Article
Reversal of tamoxifen resistance by artemisinin in ER+ breast cancer: bioinformatics analysis and experimental validation.
- Published in:
- Oncology Research, 2024, v. 32, n. 6, p. 1093, doi. 10.32604/or.2024.047257
- By:
- Publication type:
- Article
GNAS mutations suppress cell invasion by activating MEG3 in growth hormone--secreting pituitary adenoma.
- Published in:
- Oncology Research, 2024, v. 32, n. 6, p. 1079, doi. 10.32604/or.2024.046007
- By:
- Publication type:
- Article
Knockdown of HE4 suppresses tumor growth and invasiveness in lung adenocarcinoma through regulation of EGFR signaling.
- Published in:
- Oncology Research, 2024, v. 32, n. 6, p. 1119, doi. 10.32604/or.2024.045025
- By:
- Publication type:
- Article